Reversible Inhibition of Esterase Activity After Separation and Immobilization

Abstract

An inhibitor, 9-amino-1,2,3,4-tetra hydroacridine (tacrine), is a reversible inhibitor of esterases. The reversible inhibition of the enzyme activity is thought to be examined after separation and immobilization of the enzyme under non-denaturing conditions. Hydrolytic changes of phosphatidylcholine by carboxylesterase were obtained using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry after the esterase was separated by non-denaturing two-dimensional electrophoresis, was immobilized to membranes and was stained by Ponceau S. The changes were inhibited after the enzyme on the membrane was treated by tacrine. Furthermore, the hydrolytic activity of the esterase was recovered after the inhibitor was washed with aspartic acid solution. These results indicate that the phosphatidylcholine hydrolysis activity of the isolated and immobilized enzyme is reversibly inhibited under non-denaturing conditions. Furthermore, this method can be developed to the production of an enzyme reactor able to regulate amounts of lipids.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Abbreviations

2-DE:

Two-dimensional electrophoresis

PVDF:

Polyvinylidene fluoride

Tacrine:

9-Amino-1,2,3,4-tetra hydroacridine

MALDI-TOF MS:

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

CBB:

Coomassie brilliant blue

References

  1. 1.

    Marquis, J. K. (1990). Biochemical Pharmacology, 40, 1071–1076.

    Article  CAS  Google Scholar 

  2. 2.

    Bencharit, S., Morton, C. L., Hyatt, J. L., Kuhn, P., Danks, M. K., Potter, P. M., et al. (2003). Chemistry & Biology, 10, 341–349.

    Article  CAS  Google Scholar 

  3. 3.

    Smith, C. P., Bores, G. M., Petko, W., Li, M., Selk, D. E., Rush, D. K., et al. (1997). Journal of Phamacology and Experimental Therapeutics, 280, 710–720.

    CAS  Google Scholar 

  4. 4.

    Lund-Pero, M., Jeppson, B., Arneklo-Nobin, B., Sjorgen, H. O., Holmgren, K., & Pero, R. W. (1994). Clinica Chimica Acta, 224, 9–20.

    Article  CAS  Google Scholar 

  5. 5.

    Shimazaki, Y., & Watanabe, S. (2008). Clinica Chimica Acta, 390, 145–147.

    Article  CAS  Google Scholar 

  6. 6.

    Shimazaki, Y., & Kuroda, T. (2009). Biotechnology Letters, 31, 1545–1549.

    Article  CAS  Google Scholar 

  7. 7.

    Shimazaki, Y., Sugawara, Y., Ohtsuka, Y., & Manabe, T. (2003). Proteomics, 3, 2002–2007.

    Article  CAS  Google Scholar 

  8. 8.

    Shimazaki, Y., & Sakikawa, T. (2010). Protein and Peptide Letters, 17, 1048–1052.

    Article  CAS  Google Scholar 

  9. 9.

    Zschornig, O., Pietsch, M., Suß, R., Schiller, J., & Gutschow, M. (2005). Journal of Lipid Research, 46, 803–811.

    Article  Google Scholar 

  10. 10.

    Sathishkumar, M., Jayabalan, R., Mun, S. P., & Yun, S. E. (2010). Bioresource Technology, 101, 7834–7840.

    Article  CAS  Google Scholar 

  11. 11.

    He, P., Davies, J., Greenway, G., & Haswell, S. J. (2010). Analytica Chimica Acta, 659, 9–14.

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Youji Shimazaki.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sakikawa, T., Shimazaki, Y. Reversible Inhibition of Esterase Activity After Separation and Immobilization. Appl Biochem Biotechnol 165, 69–74 (2011). https://doi.org/10.1007/s12010-011-9233-z

Download citation

Keywords

  • Electrophoresis
  • Ponceau S
  • MALDI-TOF MS
  • Tacrine
  • Phosphatidylcholine